By Kelly Cloonan
Nuwellis has received a U.S. patent for its blood filtering system design and methods.
The medical technology company said Tuesday the patent covers methods for improving the accuracy of fluid balance calculations by incorporating the density of replacement fluids and effluent.
Most continuous renal replacement therapy systems assume a default fluid density, but actual fluid densities vary. If left uncorrected, that discrepancy can lead to clinically relevant fluid balance errors, the company said.
Nuwellis's design enables systems to account for density via user input, machine measurement, or derived data for more accurate volumetric flow tracking, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
July 15, 2025 16:28 ET (20:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.